Mild ANH on Pre-bypass Coagulation Function During Cardiac Surgery
NCT06664320 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70
Last updated 2024-10-31
Summary
The impact of acute normovolemic hemodilution (ANH) using hydroxyethyl starch before initiating cardiopulmonary bypass (CPB) on whole blood viscoelastic profile after CPB has not been well established. Patients undergoing cardiac surgery employing moderate hypothermic CPB are randomly allocated into one of two groups: in Group-ANH, ANH is applied by using a balanced hydroxyethyl starch (HES 130/0.6); and in Group-C, ANH is not applied. After weaning from CPB, intergroup differences of INTEM, EXTEM, FIBTEM, and APTEM profiles are analyzed. As a primary outcome, the inter-group differences between maximal clot firmness of EXTEM will be determined at 10 min after ANH in Group-ANH and that at control.
Conditions
- Mitral Regurgitation
- Mitral Stenosis
- Tricuspid Regurgitation
Interventions
- PROCEDURE
-
Acute normovolemic hemodilution (ANH)
applying acute normovolemic hemodilution (ANH) by using HES 130/0.4 of 5 ml/kg before the initiation of cardiopulmonary bypass
- DRUG
-
hydroxyethyl starch (HES 130/0.6)
hydroxyethyl starch (HES 130/0.6)
Sponsors & Collaborators
-
Konkuk University Medical Center
lead OTHER
Principal Investigators
-
Tae-Yop Kim, MD, PhD · Konkuk University Medical Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 19 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-10-28
- Primary Completion
- 2025-03-30
- Completion
- 2025-04-30
Countries
- South Korea
Study Locations
More Related Trials
-
Disinvestment in Hydroxyl-ethyl Starches (HES) for Cardiac Surgery
NCT02329158 ·Status: COMPLETED
-
The Effect of Preoperative Albumin Administration on Postoperative Acute Kidney Injury in Pediatric Patients With Hypoalbuminemia Undergoing Cardiac Surgery
NCT06710353 ·Status: RECRUITING ·Phase: NA
-
Efficacy of Prothrombin Complex Concentrate Reducing Perioperative Blood Loss in Cardiac Surgery
NCT04244981 ·Status: RECRUITING ·Phase: PHASE4
-
Goal-orientated Coagulation Management in Hypothermic Cardiac Arrest Surgery
NCT01446354 ·Status: COMPLETED
-
Individualized ANH for Non-cardiac Surgery
NCT06399536 ·Status: RECRUITING ·Phase: NA
-
Effect of Decreased Pump Prime Volume on Blood Transfusions and Postoperative Complications of Patients Undergoing High Risk Cardiac Surgical Procedures
NCT00646373 ·Status: TERMINATED ·Phase: NA
-
Application of Large Volume Acute Normovolemic Hemodilution in Cardiac Surgery
NCT04369443 ·Status: COMPLETED ·Phase: NA
-
Impact of Retrograde Autologous Priming on the Coagulation Profile Assessed by Rotation Thromboelastometry (ROTEM) in Patients Undergoing Cardiac Surgery
NCT04239677 ·Status: COMPLETED ·Phase: NA
-
Prothrombin Complex Concentrate vs Fresh Frozen Plasma in Goal-directed Bleeding Management in Cardiac Surgery
NCT06144125 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Acute Normovolemic Hemodilution in High Risk Cardiac Surgery Patients.
NCT03913481 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Impact of Fluid Restriction Policy in Reducing the Use of Red Cells in Cardiac Surgery
NCT00600704 ·Status: COMPLETED ·Phase: NA
-
Optimization of Prime Fluid Strategy to Preserve Microcirculatory Perfusion During Cardiac Surgery With Cardiopulmonary Bypass, Part II
NCT05647200 ·Status: UNKNOWN ·Phase: NA
-
Algorithm-Guided Transfusions in Cardiac Surgery Patients for Reduction of Drainage Blood Losses
NCT01402739 ·Status: TERMINATED ·Phase: NA
-
Hemodilution and Outcome in Cardiac Surgery
NCT00364494 ·Status: TERMINATED ·Phase: NA
-
Safety and Efficacy of Acute Normovolemic Hemodilution in Pediatric Cardiac Surgery Patients
NCT02751645 ·Status: UNKNOWN ·Phase: NA
-
Relationship of Point-of-care Coagulation Assays with Clinical Outcomes in Cardiac Surgery: a Retrospective Cohort Study
NCT06882759 ·Status: NOT_YET_RECRUITING
-
Impact of Intravascular Fluid Resuscitation and Whole Blood Viscosity for Cardiac Surgery
NCT02757118 ·Status: UNKNOWN ·Phase: NA
-
Ultrafiltration on Coagulation Function in Cardiac Surgery
NCT04031144 ·Status: COMPLETED ·Phase: NA
-
Effects of Fluid Therapy on Microcirculatory Reactivity
NCT04982016 ·Status: UNKNOWN ·Phase: NA
-
Point-of-Care Testing in Coagulopathic Patients Undergoing Cardiac Surgery - a Multicenter Study
NCT01826123 ·Status: UNKNOWN ·Phase: NA
-
Management of the Patient at High Risk Hemorrhagic in Cardiac Surgery by Monitoring Viscoelastic Hemostasis.
NCT06550505 ·Status: COMPLETED
-
Albumin Utilization in Adult Cardiac Surgical Patients: Retrospective
NCT06322537 ·Status: ACTIVE_NOT_RECRUITING
-
The Effect of Remote Ischemic Preconditioning in the Cardiac Surgery
NCT00997217 ·Status: COMPLETED ·Phase: PHASE1
-
Impact of Intravascular Fluid Resuscitation and Whole Blood Viscosity for CABG Surgery
NCT02757027 ·Status: UNKNOWN ·Phase: NA
-
Retrograde Versus Antegrade Perfusion in Low-Moderate Hypothermia for Aortic Arch Surgery
NCT06986967 ·Status: RECRUITING ·Phase: NA